Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma

Jianjun Gao; Neema Navai; Omar Alhalabi; Arlene O. Siefker‐Radtke; Matthew T. Campbell; Rebecca S. Tidwell; Charles C. Guo; Ashish M. Kamat; Surena F. Matin; John C. Araujo; Amishi Y. Shah; Pavlos Msaouel; Paul G. Corn; Jianbo Wang; John Papadopoulos; Shalini S. Yadav; Jorge Blando; Fei Duan; Sreyashi Basu; Wenbin Liu; Yu Shen; Yuwei Zhang; Marc Macaluso; Ying Wang; Jianfeng Chen; Jianhua Zhang; P. Andrew Futreal; Colin P. Dinney; James P. Allison; Sangeeta Goswami; Padmanee Sharma

doi:10.1038/s41591-020-1086-y

Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma

Jianjun Gao(The University of Texas MD Anderson Cancer Center), Neema Navai(The University of Texas MD Anderson Cancer Center), Omar Alhalabi(The University of Texas MD Anderson Cancer Center), Arlene O. Siefker‐Radtke(The University of Texas MD Anderson Cancer Center), Matthew T. Campbell(The University of Texas MD Anderson Cancer Center), Rebecca S. Tidwell(The University of Texas MD Anderson Cancer Center), Charles C. Guo(The University of Texas MD Anderson Cancer Center), Ashish M. Kamat(The University of Texas MD Anderson Cancer Center), Surena F. Matin(The University of Texas MD Anderson Cancer Center), John C. Araujo(The University of Texas MD Anderson Cancer Center), Amishi Y. Shah(The University of Texas MD Anderson Cancer Center), Pavlos Msaouel(The University of Texas MD Anderson Cancer Center), Paul G. Corn(The University of Texas MD Anderson Cancer Center), Jianbo Wang(The University of Texas MD Anderson Cancer Center), John Papadopoulos(The University of Texas MD Anderson Cancer Center), Shalini S. Yadav(The University of Texas MD Anderson Cancer Center), Jorge Blando(The University of Texas MD Anderson Cancer Center), Fei Duan(The University of Texas MD Anderson Cancer Center), Sreyashi Basu(The University of Texas MD Anderson Cancer Center), Wenbin Liu(The University of Texas MD Anderson Cancer Center), Yu Shen(The University of Texas MD Anderson Cancer Center), Yuwei Zhang(The University of Texas MD Anderson Cancer Center), Marc Macaluso(The University of Texas MD Anderson Cancer Center), Ying Wang(The University of Texas MD Anderson Cancer Center), Jianfeng Chen(The University of Texas MD Anderson Cancer Center), Jianhua Zhang(The University of Texas MD Anderson Cancer Center), P. Andrew Futreal(The University of Texas MD Anderson Cancer Center), Colin P. Dinney(The University of Texas MD Anderson Cancer Center), James P. Allison(The University of Texas MD Anderson Cancer Center), Sangeeta Goswami(The University of Texas MD Anderson Cancer Center), Padmanee Sharma(The University of Texas MD Anderson Cancer Center)

Nature Medicine

October 12, 2020

10.1038/s41591-020-1086-y

Cited by 312Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis